Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and L-DOPA in the rat
Open Access
- 1 November 2006
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 149 (6), 647-656
- https://doi.org/10.1038/sj.bjp.0706908
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Effects of MDMA, MDA and MDEA on blood pressure, heart rate, locomotor activity and body temperature in the rat involve α‐adrenoceptorsBritish Journal of Pharmacology, 2006
- The effects of acute loading with levodopa and levodopa with selegiline on blood pressure and plasma norepinephrine levels in chronic Parkinson's disease patientsActa Neurologica Scandinavica, 2005
- Cardiovascular activity of rasagiline, a selective and potent inhibitor of mitochondrial monoamine oxidase B: comparison with selegilineBritish Journal of Pharmacology, 2004
- Multiple-Dose Pharmacokinetics of Selegiline and Desmethylselegiline Suggest Saturable Tissue BindingClinical Neuropharmacology, 2000
- Pharmacological evidence for the presence of a peripheral postjunctional D2-like dopamine receptor in rabbit splenic arteryBritish Journal of Pharmacology, 1998
- (−)Deprenyl and (−)1-phenyl-2-propylaminopentane, [(−) PPAP] act primarily as potent stimulants of action potential — transmitter release coupling in the catecholaminergic neuronsLife Sciences, 1996
- Dopamine receptors: applications in clinical cardiology.Circulation, 1985
- The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenilJournal of Neural Transmission, 1975
- Effects of l-dopa and inhibitors of decarboxylase and monoamine oxidase on brain noradrenaline levels and blood pressure in spontaneously hypertensive ratsJournal of Pharmacy and Pharmacology, 1972
- On the localization of the hypotensive effect of L-dopaJournal of Pharmacy and Pharmacology, 1972